IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study ; volume:5 ; number:1 ; day:18 ; month:11 ; year:2016 ; pages:1-13 ; date:12.2016
SpringerPlus ; 5, Heft 1 (18.11.2016), 1-13, 12.2016
- Beteiligte Personen und Organisationen
-
Mangia, Alessandra
Ledinghen, Victor De
Bailly, François
Brahm, Javier
Keiss, Jazeps
Valantinas, Jonas
Rasmann, Nele
Messinger, Diethelm
Tatsch, Fernando
Bakalos, Georgios
Foster, Graham R.
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-3663-6
- URN
-
urn:nbn:de:1111-201612099109
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mangia, Alessandra
- Ledinghen, Victor De
- Bailly, François
- Brahm, Javier
- Keiss, Jazeps
- Valantinas, Jonas
- Rasmann, Nele
- Messinger, Diethelm
- Tatsch, Fernando
- Bakalos, Georgios
- Foster, Graham R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype
Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
Liver cirrhosis
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype
Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
Liver cirrhosis
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype
Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
Liver cirrhosis